IFNG and neoplasm: The mechanisms of acquired resistance in ICIs can be broadly classified into the following categories[104]: (1) defects in antigen-presentation mechanisms; (2) defects in the IFN-γ signaling pathway; (3) tumor-mediated immunosuppression; (4) other inhibitory checkpoints; and (5) clonal evolution and neoantigen loss.